Exosomes from Adipose-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw by Inhibiting Macrophage M1 Polarization and Pyroptosis
Yi Zheng,Xinyu Wang,Yang He,Shuo Chen,Linhai He,Yi Zhang
DOI: https://doi.org/10.2147/ijn.s482849
IF: 7.033
2024-11-28
International Journal of Nanomedicine
Abstract:Yi Zheng, 1, 2 Xinyu Wang, 1 Yang He, 1 Shuo Chen, 1 Linhai He, 1, 3, &ast Yi Zhang 1, &ast 1 Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, 100081, People's Republic of China; 2 Department of Stomatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China; 3 First Clinical Division, Peking University School and Hospital of Stomatology, Beijing, 100081, People's Republic of China &astThese authors contributed equally to this work Correspondence: Linhai He; Yi Zhang, Email ; Purpose: Exosomes from mesenchymal stromal cells (MSCs) can prevent the development of medication-related osteonecrosis of the jaw (MRONJ) by promoting tooth socket wound healing; however, the exact mechanism remains to be clarified. In this study, our aim was to explore the mechanisms of exosomes derived from adipose-derived mesenchymal stromal cells (ADSCs) in preventing MRONJ by focusing on macrophage M1 polarization and pyroptosis. Methods: The MRONJ model was established by the administration of zoledronate and tooth extraction. Exosomes isolated from the supernatant of ADSCs were mixed with hydrogel and locally injected into the extraction site after tooth extraction. Stereoscope observations, micro computed tomography (microCT), and histological analysis were used to assess tooth socket wound healing. Results: The results showed that exosomes could effectively avoid MRONJ via accelerating gingival wound healing and tooth socket bone regeneration. Mechanistically, zoledronate triggered the NF-κB signaling pathway and promoted p65 transferring into the nucleus in macrophages, resulting in macrophage M1 polarization and pyroptosis-mediated tissue inflammation, while exosomes could reduce macrophage pyroptosis and pro-inflammation cytokines release by suppressing the NF-κB/NLRP3/IL-1β axis. Additionally, IL-1RA derived from exosomes plays a key role in preventing MRONJ. Pyroptosis-related and inflammatory-related processes were upregulated in MRONJ patients further confirmed by assessing MRONJ gingival samples and healthy gingival tissues. Conclusion: ADSCs-derived exosomes could effectively promote tooth socket healing and prevent MRONJ by inhibiting M1 macrophage activation and pyroptosis by blocking the NF-κB/NLRP3/IL-1β axis. Keywords: Medication-related osteonecrosis of the jaw, exosomes, macrophage M1 polarization and pyroptosis, primary wound healing, NF-κB/NLRP3/IL-1β axis MRONJ is a rare and debilitating condition characterized by progressive bone destruction in the maxillofacial region in patients with a history of antiangiogenic or antiresorptive agents, which are commonly used to treat bone-metastatic cancers, Paget's disease, osteoporosis, multiple myeloma, and osteogenesis imperfecta. 1–3 The hypotheses of MRONJ pathophysiology include bone remodeling inhibition, angiogenesis inhibition, inflammation or infection, immune dysfunction, and genetic predisposition. However, these hypotheses have not been fully confirmed, and the pathogenesis of MRONJ still needs to be explored. 1,4 Also, the therapeutic efficiency remains limited. Treatment of MRONJ typically involves surgical interventions and drug therapy. However, the success rate of surgical management is approximately 61–89%, and MRONJ may recur after surgery. 5 Recently, hyperbaric oxygen therapy, platelet-rich plasma, and low-level light therapy have been proven to be effective for MRONJ. 4 Currently, the optimal treatment for MRONJ has not been determined, and consensus on the sequential treatment of MRONJ still needs further study. MSCs therapy has been suggested as an alternative but effective option for MRONJ. 6–9 ADSCs are derived from adipose tissue and have advantages over other MSCs due to their rich sources, high yield, simple access, and little harm to the donor. 10,11 However, the clinical application of MSCs therapy raises some safety concerns, such as the risk of promoting tumor growth and metastasis. 12 Emerging evidence has shown that paracrine signaling is the key mechanism of MSCs therapeutic efficacy to exert regenerative and immunomodulatory potential. 13 Exosomes (Exo) are important paracrine products of cell culture supernatant, which can transfer bioactive cargo to target cells, including nucleic acids, metabolites, proteins, and, lipids, mediating specific intracellular signaling pathways. 14–16 As Exo can move through body fluids like blood, saliva, and urine, reaching distant cells and tissues, t -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology